Baltimore-Washington Financial Advisors »

Immunocellular Thera shares owned by Baltimore-Washington Financial Advisors

Quarter-by-quarter ownership of Immunocellular Thera shares owned by Baltimore-Washington Financial Advisors from 13F filings

Historical chart of Baltimore-Washington Financial Advisors investment in Immunocellular Thera

Tip: Access up to 7 years of quarterly data

All positions including Immunocellular Thera held by Baltimore-Washington Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunocellular Thera by Baltimore-Washington Financial Advisors

Quarter filed Position value Share count Share price at filing
2013-09-30 $5.0k 2.0k 2.50

More positions owned by Baltimore-Washington Financial Advisors

iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Vodafone
Plains All American Pipeline (PAA)
Aberdeen Asia-Pacific Income Fund (FAX)
Rayonier (RYN)
Pepsi (PEP)
Vanguard Short Term Corporate Bond ETF (VCSH)
Johnson Controls
Rockwell Automation (ROK)
Occidental Petroleum Corporation (OXY)
Apple (AAPL)
Cal-Maine Foods (CALM)
ConocoPhillips (COP)
United Technologies Corporation
Dow Chemical Company

View all positions for Baltimore-Washington Financial Advisors